These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15470595)

  • 1. American Society for Virology-23rd annual meeting. Vaccines and antiviral agents 10-14 July 2004, Montreal Canada.
    Barnard DL
    IDrugs; 2004 Sep; 7(9):822-4. PubMed ID: 15470595
    [No Abstract]   [Full Text] [Related]  

  • 2. The preparation of viral vaccines containing purified extracted antigens.
    Kanarek AD; Tribe GW
    Prog Immunobiol Stand; 1967; 3():165-9. PubMed ID: 4314426
    [No Abstract]   [Full Text] [Related]  

  • 3. Developments in antiviral drug design, discovery and development in 2004.
    Meanwell NA; Belema M; Carini DJ; D'Andrea SV; Kadow JF; Krystal M; Naidu BN; Regueiro-Ren A; Scola PM; Sit SY; Walker MA; Wang T; Yeung KS
    Curr Drug Targets Infect Disord; 2005 Dec; 5(4):307-400. PubMed ID: 16535860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral properties of 1-phenoxymethyl-3,4-dihydro and 1,2,3,4-tetrahydroisoquinolines.
    Brammer KW; McDonald CR; Tute MS
    Nature; 1968 Aug; 219(5153):515-7. PubMed ID: 4299256
    [No Abstract]   [Full Text] [Related]  

  • 5. News and views from the 8th annual meeting of the Italian Society of Virology.
    Sartori E; Salata C; Calistri A; Palù G; Parolin C
    J Cell Physiol; 2009 Jun; 219(3):797-9. PubMed ID: 19235903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Predictors of Mortality After Ribonucleic Acid Virus Infection.
    Graham JB; Swarts JL; Menachery VD; Gralinski LE; Schäfer A; Plante KS; Morrison CR; Voss KM; Green R; Choonoo G; Jeng S; Miller DR; Mooney MA; McWeeney SK; Ferris MT; Pardo-Manuel de Villena F; Gale M; Heise MT; Baric RS; Lund JM
    J Infect Dis; 2020 Mar; 221(6):882-889. PubMed ID: 31621854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral action of gliotoxin.
    McDougall JK
    Arch Gesamte Virusforsch; 1969; 27(2):255-67. PubMed ID: 4313024
    [No Abstract]   [Full Text] [Related]  

  • 8. The new generation of recombinant viral subunit vaccines.
    Ellis RW
    Curr Opin Biotechnol; 1996 Dec; 7(6):646-52. PubMed ID: 8939634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infectious disease. West Nile drugs, vaccine still years away.
    Enserink M
    Science; 2000 Nov; 290(5496):1483. PubMed ID: 11185501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of antiviral therapy for severe acute respiratory syndrome.
    Cinatl J; Michaelis M; Hoever G; Preiser W; Doerr HW
    Antiviral Res; 2005 Jun; 66(2-3):81-97. PubMed ID: 15878786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models and antibody assays for evaluating candidate SARS vaccines: summary of a technical meeting 25-26 August 2005, London, UK.
    Roberts A; Wood J; Subbarao K; Ferguson M; Wood D; Cherian T
    Vaccine; 2006 Nov; 24(49-50):7056-65. PubMed ID: 16930781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New pandemics: HIV and AIDS, HCV and chronic hepatitis, influenza virus and flu.
    Gatignol A; Dubuisson J; Wainberg MA; Cohen EA; Darlix JL
    Retrovirology; 2007 Feb; 4():8. PubMed ID: 17270043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activity of gliotoxin.
    Larin NM; Copping MP; Herbst-Laier RH; Roberts B; Wenham RB
    Chemotherapy; 1965; 10(1):12-23. PubMed ID: 4285752
    [No Abstract]   [Full Text] [Related]  

  • 14. The 17th International Conference on Antiviral Research.
    Buckheit RW
    Expert Opin Investig Drugs; 2004 Sep; 13(9):1207-12. PubMed ID: 15330752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virology. The SARS coronavirus: a postgenomic era.
    Holmes KV; Enjuanes L
    Science; 2003 May; 300(5624):1377-8. PubMed ID: 12775826
    [No Abstract]   [Full Text] [Related]  

  • 16. MTT colorimetric assay system for the screening of anti-orthomyxo- and anti-paramyxoviral agents.
    Watanabe W; Konno K; Ijichi K; Inoue H; Yokota T; Shigeta S
    J Virol Methods; 1994 Jul; 48(2-3):257-65. PubMed ID: 7989442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viruses in and out.
    Andrawiss M
    Genome Biol; 2002 Sep; 3(10):REPORTS4033. PubMed ID: 12374574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential antiviral agents. Carbobenzoxy di- and tripeptides active against measles and herpes viruses.
    Nicolaides E; DeWald H; Lipnik M; Westland R; Posler J
    J Med Chem; 1968 Jan; 11(1):74-9. PubMed ID: 4295313
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent developments in the virology and antiviral research of severe acute respiratory syndrome coronavirus.
    Yeung KS; Meanwell NA
    Infect Disord Drug Targets; 2007 Mar; 7(1):29-41. PubMed ID: 17346209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody World Summit 2004-SRI Conference 19-21 July 2004, Philadelphia, PA, USA.
    Nock S
    IDrugs; 2004 Sep; 7(9):825-8. PubMed ID: 15470596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.